{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:38:08Z","timestamp":1760027888705},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ejim.2011.05.002","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T08:55:02Z","timestamp":1308473702000},"page":"616-620","source":"Crossref","is-referenced-by-count":12,"title":["Calcium channel antagonist exposures reported to the Poisons Information Center Erfurt"],"prefix":"10.1016","volume":"22","author":[{"given":"M.","family":"Deters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Enden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Liebetrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Plenert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Prasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hentschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2011.05.002_bb0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ajem.2004.06.001","article-title":"2003 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System","volume":"5","author":"Watson","year":"2004","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ejim.2011.05.002_bb0010","series-title":"Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient","first-page":"413","article-title":"Calcium channel-blocking agents","author":"Brent","year":"2005"},{"key":"10.1016\/j.ejim.2011.05.002_bb0015","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjp.0702162","article-title":"The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunits","volume":"125","author":"Morel","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejim.2011.05.002_bb0020","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1074\/jbc.270.18.10540","article-title":"Different voltage-dependent inhibition by dihydropyridines of human Ca2+- channel splice variants","volume":"270","author":"Soldatov","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejim.2011.05.002_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/15563659809028940","article-title":"Poisoning Severity Score. Grading of acute poisoning","volume":"36","author":"Persson","year":"1998","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ejim.2011.05.002_bb0030","series-title":"Arzneiverordnungsreport 2010","first-page":"491","article-title":"Calciumantagonisten","author":"Eschenhagen","year":"2010"},{"key":"10.1016\/j.ejim.2011.05.002_bb0035","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"Abernathy","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.05.002_bb0040","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2165\/00002018-199106060-00003","article-title":"Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine","volume":"6","author":"Pearigen","year":"1991","journal-title":"Drug Saf"},{"key":"10.1016\/j.ejim.2011.05.002_bb0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0196-0644(05)82469-2","article-title":"Calcium channel blocker toxicity","volume":"19","author":"Ramoska","year":"1990","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ejim.2011.05.002_bb0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0196-0644(05)80202-1","article-title":"A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment","volume":"22","author":"Ramoska","year":"1993","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ejim.2011.05.002_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/096032719401300304","article-title":"Calcium channel blocking drug overdose: an Australian series","volume":"13","author":"Howarth","year":"1994","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.ejim.2011.05.002_bb0060","series-title":"Goldfrank's Toxicologic Emergencies","first-page":"884","article-title":"Calcium channel blockers","author":"DeRoos","year":"2010"},{"key":"10.1016\/j.ejim.2011.05.002_bb0065","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/clpt.1989.167","article-title":"Synergistic adverse hemodynamic interaction between oral verapamil and propranolol","volume":"46","author":"Carruthers","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ejim.2011.05.002_bb0070","first-page":"249","article-title":"Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol","volume":"35","author":"Jolly","year":"1987","journal-title":"Pharmcology"},{"key":"10.1016\/j.ejim.2011.05.002_bb0075","first-page":"292","article-title":"Life-threatening bradycardia reactions due to beta blocker-diltiazem interactions","volume":"28","author":"Yust","year":"1992","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.ejim.2011.05.002_bb0080","series-title":"Prod Product Information: Catapres-TTS(R) transdermal therapeutic system patch, clonidine transdermal therapeutic system patch","year":"2010"},{"key":"10.1016\/j.ejim.2011.05.002_bb0085","series-title":"Product Information: VERELAN(R)PM extended-release oral capsules, verapamil hydrochloride extended-release oral capsules","year":"2009"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511000938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511000938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T06:51:11Z","timestamp":1543733471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620511000938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0953620511000938"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2011.05.002","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}